MINI REVIEW article

Front. Cell Dev. Biol., 08 March 2021

Sec. Cell Growth and Division

Volume 9 - 2021 | https://doi.org/10.3389/fcell.2021.648057

Oocyte Spontaneous Activation: An Overlooked Cellular Event That Impairs Female Fertility in Mammals

  • Department of Veterinary and Animal Sciences, Animal Models Core Facility, Institute for Applied Life Sciences (IALS), University of Massachusetts Amherst, Amherst, MA, United States

Abstract

In mammals, including humans, mature oocytes are ovulated into the oviduct for fertilization. Normally, these oocytes are arrested at metaphase of the second meiosis (MII), and this arrest can be maintained for a certain period, which is essential for fertilization in vivo and oocyte manipulations in vitro, such as assisted reproduction in clinics and nuclear/spindle transfer in laboratories. However, in some species and under certain circumstances, exit from MII occurs spontaneously without any obvious stimulation or morphological signs, which is so-called oocyte spontaneous activation (OSA). This mini-review summarizes two types of OSA. In the first type (e.g., most rat strains), oocytes can maintain MII arrest in vivo, but once removed out, oocytes undergo OSA with sister chromatids separated and eventually scattered in the cytoplasm. Because the stimulation is minimal (oocyte collection itself), this OSA is incomplete and cannot force oocytes into interphase. Notably, once re-activated by sperm or chemicals, those scattered chromatids will form multiple pronuclei (MPN), which may recapitulate certain MPN and aneuploidy cases observed in fertility clinics. The second type of OSA occurs in ovarian oocytes (e.g., certain mouse strains and dromedary camel). Without ovulation or fertilization, these OSA-oocytes can initiate intrafollicular development, but these parthenotes cannot develop to term due to aberrant genomic imprinting. Instead, they either degrade or give rise to ovarian teratomas, which have also been reported in female patients. Last but not the least, genetic models displaying OSA phenotypes and the lessons we can learn from animal OSA for human reproduction are also discussed.

Introduction

Except some species (e.g., canine), mammalian females ovulate mature metaphase-II (MII) oocytes into the oviduct following luteinizing hormone (LH)-triggered oocyte maturation and follicular rupture (; ). Normally, these ovulated oocytes can maintain MII arrest for a certain period until fertilization occurs (; Yin et al., 2008). Maintaining at MII stage is essential for not only fertilization in vivo but also oocyte manipulations in vitro, such as assisted reproduction, nuclear transfer cloning, and other therapeutic approaches (Sun et al., 2014; ; ). However, in some species and under certain circumstances, exit from MII occurs spontaneously without any obvious stimulation or morphological signs, which is so-called oocyte spontaneous activation (OSA). In this mini-review, we highlight insights gained on two types of OSA through various animal models and discuss the effects of OSA on human fertility and reproductive health.

First Type of OSA

In the first type of OSA (type-1 OSA) (Figure 1A), ovulated mature oocytes can maintain MII arrest in vivo (in the oviduct); however, once collected out without any obvious or artificial stimulation, oocytes undergo OSA. In other words, these oocytes have very limited ability to maintain the MII arrest, and only oocyte recovery procedure itself can trigger parthenogenetic activation in these oocytes. This type of OSA has been known and studied in multiple species, mainly on rat (; Zernicka-Goetz, 1991) and golden hamster (; Sun et al., 2002), together with case reports from human in vitro fertilization (IVF) clinics (Van Blerkom et al., 1994; ; Ye et al., 2020).

FIGURE 1

Morphological and cytoskeletal changes during type-1 OSA have been relatively well studied in rats. The initial separation of sister chromatids is similar to normal MII-to-AII (anaphase II) transition as seen in sperm or chemical-induced meiotic resumption and oocyte activation (; ). Following this, oocytes either extrude the second polar body (2nd PB) or just exhibit a protrusion without 2nd PB extrusion or even no obvious change at all, depending on the oocyte postovulatory age, rat strain, external environment, and microtubule integrity (Zernicka-Goetz, 1991; ; ; ). When OSA is done (normally around 6 h post in vitro culture), scattered chromatids and surrounding microtubules form multiple small spindle-like structures, reaching a new metaphase-like arrest (Zernicka-Goetz et al., 1993; Tomioka et al., 2007; ). Because the stimulation is minimal (oocyte collection itself and the following in vitro culture), this OSA is incomplete/abortive and cannot force oocytes into interphase, and therefore, no pronucleus formation occurs after OSA. Instead, OSA-oocytes enter a so-called “metaphase III-like” (M-III) arrest (Zernicka-Goetz, 1991). Notably, these OSA-oocytes can be re-activated by sperm or chemicals, and once re-activated, those scattered chromatids will form multiple pronuclei (MPN), which may recapitulate certain MPN and aneuploidy cases observed in human fertility clinics (Van Blerkom et al., 1984; ; ; ; ). Different from rat, some hamster and human OSA-oocytes can reach interphase with visible pronuclei (; Van Blerkom et al., 1994; Sun et al., 2002; ; ; Ye et al., 2020).

Mechanism and Control of Type-1 OSA

Although no obvious or artificial stimulation is applied on OSA-oocytes, substantial subtle changes could happen during oocyte collection and in vitro culture. Among all factors, exposure to cold and prolonged retention in the oviduct after animal sacrifice can significantly increase rat OSA (; Zernicka-Goetz, 1991; ). Another widely recognized factor is postovulatory aging, which has been shown in rat (; ; ), golden hamster (Sun et al., 2002; ), and human () to facilitate OSA (Table 1). Same as other vertebrates, the two most critical kinases of cytostatic factor (CSF), maturation-promoting factor (MPF), and mitogen-activated protein kinase (MAPK), are also involved in OSA (Tiwari et al., 2018). Previous studies revealed that rat oocytes carry only 40% MPF kinase activity of that in mouse oocytes (), which could explain the susceptibility of rat oocytes to OSA, although variation in MPF activity has been detected among different rat strains (; ; Sterthaus et al., 2009). As a master regulator of microtubule organization and spindle assembly during oocyte meiosis, MAPK, the other pivotal CSF, has also been studied in rat OSA. Different from sperm or chemical-induced oocyte activation where high MAPK activity still lasts several hours after the stimulation (), rat OSA exhibits a quick decrease in both Mos and MAPK kinase (MEK)/MAPK (; Table 1), which could explain the reason underlying the disintegrated microtubules and failure of 2nd PB extrusion during OSA in some rat strains (; ). Regarding the mechanism of re-entering the so-called M-III arrest after OSA, a plausible scenario is that defects in attachment of kinetochores and/or spindle assembly caused by premature MAPK decline could activate the spindle assembly checkpoint (SAC) proteins, which then mobilize cyclin B protein and actuate MPF activity ().

TABLE 1

FactorEffect and how to controlReferences
TemperatureAvoid temperature change during oocyte collection from oviduct to mediumZernicka-Goetz, 1991;
Time interval between animal euthanasia and oocyte collectionShorten the time interval and do animal sacrifice and oocyte collection one by one instead of a batch;
Oocyte postovulatory ageAvoid oocyte postovulatory aging in vivo; Sun et al., 2002;
Initial MPF levelRat oocytes carry only 40% MPF kinase activity of that in mouse oocytes
Timing of MAPK declineRat OSA exhibits a quick decrease in both Mos and MAPK kinase (MEK)/MAPK
Spindle assembly checkpoint (SAC)Premature MAPK decline disintegrates microtubules and activates the SAC proteins, which then mobilize cyclin-B protein and bring oocytes to M-III
Ca2+ and calmodulin-dependent protein kinase II (CaMKII)Ca2+ and CaMKII cascade contribute to MPF inactivation and premature MAPK decline. Ca2+-free medium, Ca2+ chelator, Ca2+ channel blockers, NCX1 activator, and CaMKII inhibitors have been applied, but these methods cannot fully block OSA or can cause obvious side effects; Sun et al., 2002; ; ; ; Yoo and Smith, 2007;
Cyclin-B degradation during OSATo inhibit cyclin-B degradation and MPF inactivation, proteasome inhibitor MG132 was widely applied, but caution should be exercised due to its profound side effectsZhou et al., 2003; ; ; ;
Rat strainsDifferent rat strains exhibit different MPF activities and distinct susceptibility to OSA; ; Sterthaus et al., 2009
Other factorsNitric oxide, cyclin-dependent kinase 1, ubiquitin-proteasome pathway, and reactive oxygen species.Tan et al., 2005; ; ; ,;

Factors that are involved in type-1 OSA.

Similar to sperm and chemical-induced mammalian oocyte activation (; ), Ca2+ and calmodulin-dependent protein kinase II (CaMKII) are also involved in OSA attributing to MPF inactivation and probably a premature decline in Mos/MEK/MAPK (; ; Yoo and Smith, 2007; Table 1). It is noteworthy that increase of intracellular free Ca2+ [(Ca2+)i] during OSA is insufficient (; ) compared with the pattern caused by sperm or chemical, which could explain why OSA is incomplete and abortive that cannot force oocytes into interphase to form pronucleus. To block increase of (Ca2+)i and its cascade during OSA, Ca2+-free medium (; Sun et al., 2002; ), Ca2+ chelator (), multiple Ca2+ channel blockers (; Yoo and Smith, 2007), and CaMKII inhibitors (; Yoo and Smith, 2007) have been applied (Table 1), but these methods cannot fully block OSA or can cause obvious side effects [reviewed in ]. A novel physiological method focusing on sodium/calcium exchanger-mediated Ca2+ efflux has been demonstrated effective to block OSA, but this method cannot override the stimulation caused by enucleation during somatic cell nuclear transfer (SCNT) (). To inhibit cyclin-B degradation and MPF inactivation, proteasome inhibitor MG132 was also widely applied (Zhou et al., 2003; ; ; Sterthaus et al., 2009; ; ), but caution should be exercised due to its profound side effects [reviewed in ]. Furthermore, other factors have also been evaluated to better elucidate type-1 OSA, such as intracellular nitric oxide (; ), cyclin-dependent kinase 1 (,), ubiquitin-proteasome pathway (Tan et al., 2005), and reactive oxygen species (). To summarize, although more factors and pathways involved in type-1 OSA are emerging (Table 1), the nature of trigger and the best way to prevent the onset of OSA are still unclear. With advancement in rat and hamster genome editing especially under CRISPR/Cas9 system (; ), we hope a clear picture of type-1 OSA could be achieved soon.

“Confusing” Terms

Given the theme of this mini-review and the following content (type-2 OSA) to discuss, it seems helpful to clarify some “confusing” terms here.

Spontaneous Meiotic Resumption

Once mammalian oocytes are separated from the antral follicles and cultured under appropriate conditions, they can resume meiosis spontaneously from the diplotene stage of the first meiotic prophase to MII, which is also called spontaneous maturation (; ).

Spontaneous Ovulation

Most mammals including women display a continuous cycling of reproductive hormones with ovulation occurring at regular intervals, which is different from those induced ovulators (e.g., rabbits, cats, and camelids) that copulation is responsible for hormone regulation and ovulation ().

Postovulatory Oocyte Aging vs. OSA

Normally, mature oocytes can maintain MII arrest for a certain period in vivo or in vitro. If fertilization does not occur, oocytes undergo postovulatory oocyte aging, and too “aged” oocytes may GRADUALLY exit MII arrest with some initiating OSA (; Xu et al., 1997; ; ). In short, long-time postovulatory oocyte aging may facilitate OSA both in vivo and in vitro, but OSA can also occur in very “young and fresh” oocytes, and OSA process is relatively much faster and uncontrollable (discussed in section “First Type Of OSA”).

Type-2 OSA and Mechanism

Although oocytes spend majority of their life in the ovary and follicles, to become an embryo, it has to be ovulated from the follicle into oviduct for fertilization with sperm. However, OSA-induced embryogenesis is an exception. The second type of OSA (Figure 1B) occurs in ovarian oocytes within the follicles and it can initiate intrafollicular development to a certain stage. For example, in LT/Sv mice, a substantial portion of oocytes that have completed the first meiotic division can undergo OSA (). Although these ovarian OSA-embryos resemble normal until the blastocyst or even primitive streak stage, later on, most of them become disorganized and form ovarian teratomas (Stevens and Varnum, 1974). Usually, these teratomas are benign, but occasionally, they grow progressively and are malignant, containing multiple types of tissue and proliferating pluripotent stem cells (embryonal carcinoma cells that are called teratocarcinomas) (Stevens, 1980). Notably, these phenotypes were also reported in humans, including ovarian zygotes (), two-cell embryo (), four-cell embryo (), and teratomas (). To clarify, the existence of nuclei had been confirmed in all blastomeres of the above-mentioned human ovarian OSA-embryos, ruling out the possibly of cytoplasmic fragmentation, which is a relatively common phenomenon in aged unfertilized oocytes or during human preimplantation development (; ).

In addition to spontaneous ovulators, type-2 OSA and ovarian teratoma have also been detected in induced ovulators, such as dromedary camel (Camelus dromedarius) (, ). Similarly, OSA-oocytes can initiate intrafollicular development to blastocyst stage with clear inner cell mass and trophectoderm (, ), suggesting the occurrence of the first cell lineage specification in these parthenotes (; ). Although the underlying molecular mechanism that causes type-2 OSA is not fully understood yet, current knowledge from mouse models suggests that type-2 OSA and teratoma formation are multigenic traits (), involving genetic background (; ; ; ), cytoskeletal arrangement and SAC (; ), companion somatic cells (), AMPK signaling (; Ya and Downs, 2013), and hormonal regulation (Speirs and Kaufman, 1988).

Genetic Models Displaying OSA Phenotypes

With success in embryonic stem cell (ESC)-mediated gene targeting and CRISPR/Cas9-mediated genome editing, more engineered animal models have been generated for studying mammalian oocyte meiosis. Here, we briefly review some examples.

Mos knockout female mice can produce MII oocytes; however, these oocytes cannot arrest at MII stage (Figure 1C). For those ovulated MII oocytes, they will spontaneously extrude 2nd PB and reach M-III, followed by pronucleus formation and cell divisions. Meanwhile, unovulated OSA-oocytes can initiate intrafollicular development, which then causes ovarian teratomas (; ; ). In addition, Mos– oocytes frequently produce large first polar bodies (1st PBs) due to the failure of metaphase spindle movement (; Verlhac et al., 1996). Given the phenotypes detected from the knockout mice, these models are valuable for studying human ovarian pathology and teratogenesis.

Although MOS/MEK/ERK cascade has been relatively well studied in oocyte meiosis, the explicit role of extracellular signal-regulated kinase (ERK) in vivo was not clear. Through the knockout of both Erk1 and Erk2 in mouse oocytes (Figure 1D), data indicates that Erk1/2– oocytes exit MII arrest and extrude 2nd PB spontaneously, reaching M-III stage. Different from Mos– oocytes, Erk1/2– MII oocytes do not exhibit large 1st PBs, and subsequent M-III oocytes display low frequency of pronucleus formation, explaining why ovarian teratomas were not detected in the females. Interestingly, ERK1/2 deletion also severely prevents male pronucleus formation after fertilization (Zhang et al., 2015), representing another major contributing cause of female infertility.

Female fertility can be affected by many factors, including diet and nutrient metabolism. Two recent studies using genetically modified mice revealed that maintenance of cholesterol within a physiological range during oocyte development and maturation is essential for female fertility. Excess cholesterol deposition in MII oocytes can induce an elevation of (Ca2+)i, which then triggers reduction in both MPF and MAPK, leading to OSA and extrusion of 2nd PB to M-III (Figure 1E). Different from all the above-mentioned OSAs, this cholesterol-induced OSA can result in multiple cell cycles, including execution of the third meiosis with extrusion of 3rd PB (Yesilaltay et al., 2014; ), which was found in partially activated oocytes (). Importantly, this excess-cholesterol-induced OSA can be reversed both in vivo and in vitro (Yesilaltay et al., 2014; ), highlighting the possibility that cholesterol metabolism may underlie some woman infertility of unknown etiology and this could be cured with appropriate treatments.

In mammals, oocyte meiotic maturation not only produces a haploid gamete but also initiates maternal mRNA transition from stable to unstable (Wu and Dean, 2016; ), serving as a prolog to maternal-zygotic transition (MZT) which involves maternal mRNA destabilization and degradation. Recently, three laboratories independently identified BTG4 as a key mediator that links mRNA decay machinery and meiotic cell cycle progression, and loss of BTG4 causes a global delay in maternal mRNA degradation (; ; Yu et al., 2016). In addition, BTG4 was also identified as essential for MII arrest (Figure 1F), because excess polyadenylated mRNA caused by Btg4 knockdown could occupy the translational machinery, which then leads to an insufficient capacity of the oocyte to translate the mRNAs that are essential for MII arrest (e.g., mRNAs encoding EMI2), and all of this finally resulted in OSA to M-III (). Interestingly, this OSA phenotype was not detected in knockout models, which could be due to the environment (in vitro live imaging vs. in vivo) and/or methodologies (difference in genetic compensation and specificity between knockdown and knockout).

Discussion

We reviewed two types of OSA and representative animal models exhibiting OSA phenotypes due to genetic defects. Regarding type-1 OSA (in vivo to in vitro), we propose that more caution should be exercised during assisted human reproduction, as many steps could trigger OSA, such as oocyte retrieval (), cryopreservation (), and intracytoplasmic sperm injection (ICSI) (Sultan et al., 1995). Furthermore, as learned from rat OSA, certain OSA-oocytes could show minimal morphological signs (e.g., sister chromatids separated or even scattered in cytoplasm but without 2nd PB or pronucleus formation). Therefore, we propose OSA should be considered for those unexplained abnormal fertilization with repeated triploid pronuclei (3PN) () or even more pronuclei (e.g., up to 8PN) () after ICSI. Other lessons we can learn from animal models and issues that should be addressed are as follows: (1) time interval between oocyte pickup and IVF/ICSI. Currently, there is no consensus among clinics about this interval, and 2–6 h are widely accepted for a better cytoplasmic maturity but without aging (Van de Velde et al., 1998; ). This routine interval seems fine for most patients; however, for those that cannot achieve pregnancy after multiple cycles and especially with repeated 3PN or MPN, this interval probably needs to be avoided as OSA could be the reason that is much faster than natural aging. (2) Make everything ready for a rapid ICSI. For oocytes that are susceptible to OSA (; ), all things should be well prepared before oocyte retrieval; right after which, a careful and rapid oocyte denudation and ICSI should follow to mitigate OSA-induced abnormal fertilization and possible aneuploidy.

A substantial number of patients cannot achieve successful pregnancy after multiple IVF cycles, and it is generally believed that genetic defects underlie many of these unrecognized pathologies (; ). Dissecting the association between genetic variants and human OSA is challenging because the etiology is highly heterogeneous and patients have different genetic predispositions and epigenetic modifications (; ), ages and lifestyles (; ), and exposures to diverse environments and pollutants (). To gain a better understanding of human oocyte meiosis and idiopathic infertility, animal models have been generated to define key factors and pathways involved in meiotic cell cycle regulation. Although more than 400 mutant mouse models with reproductive phenotypes have been established (), many genes and pathways regulating oocyte meiosis and OSA are still not fully delineated due to insufficient models and possible limitations when translating the information from mice to humans. With more mouse models being generated by the Knockout Mouse Program and the International Mouse Phenotyping Consortium1 and recent application of CRISPR/Cas9 in other species that can bypass barriers of ESCs and SCNT, we believe more essential genes will be screened out and more appropriate animal models (e.g., point mutation by knock-in) will be generated. We hope, with more precise animal models available, more sophisticated clinical protocols (; Socolov et al., 2015), faster genetic tests in clinics, more advanced assisted reproductive technologies (Smith and Takayama, 2017; ; ), and genetic diagnosis in preimplantation embryos, we will fully understand the underpinnings of human OSA, an overlooked meiotic instability problem that requires global attention ().

Statements

Author contributions

WC conceived the study, prepared the figures, and wrote the manuscript.

Funding

This work was supported by grants from the National Institutes of Health/National Institute of Child Health and Human Development (NIH/NICHD R21HD098686) and USDA National Institute of Food and Agriculture/Hatch (NIFA/Hatch #1024792) to WC. The contents are solely the responsibility of the author and do not necessarily represent the official views of the funding agencies.

Conflict of interest

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

Summary

Keywords

meiosis, cell cycle, assisted reproduction, ovarian teratoma, multiple pronuclei, aneuploidy, metaphase arrest, triploid pronuclei

Citation

Cui W (2021) Oocyte Spontaneous Activation: An Overlooked Cellular Event That Impairs Female Fertility in Mammals. Front. Cell Dev. Biol. 9:648057. doi: 10.3389/fcell.2021.648057

Received

31 December 2020

Accepted

08 February 2021

Published

08 March 2021

Volume

9 - 2021

Edited by

Shao-Chen Sun, Nanjing Agricultural University, China

Reviewed by

Hai-Long Wang, Xiamen University, China; Junya Ito, Azabu University, Japan; Chuan Zhou, University of California, Davis, United States

Updates

Copyright

*Correspondence: Wei Cui,

This article was submitted to Cell Growth and Division, a section of the journal Frontiers in Cell and Developmental Biology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics